<DOC>
	<DOCNO>NCT02775786</DOCNO>
	<brief_summary>This prospective cohort study participant pancreatic adenocarcinoma undergo surgical resection . Participants two magnetic resonance imaging ( MRI ) scan without intravenous contrast . The MRI perform use either extracellular contrast agent use macromolecular contrast agent . These contrast agent routinely use body MRI formulary institution . Parameters compare histopathology measure mean vascular density grade fibrosis , respectively . The purpose establish standard protocol future clinical trial treatment would use MRI parameter quantitative marker treatment effect .</brief_summary>
	<brief_title>Prospective Evaluation MRI Biomarkers Pancreatic Ductal Adenocarcinoma</brief_title>
	<detailed_description>This prospective cohort study dynamic contrast enhance MRI ( DCE-MRI ) , include diffusion weight imaging ( DWI-MRI ) participant pancreatic adenocarcinoma undergo surgical resection . Participants two MRI scan without intravenous contrast . The MRI perform use either extracellular contrast agent use macromolecular contrast agent . These contrast agent routinely use body MRI formulary institution . Quantitative parameter volume transfer coefficient ( Ktrans ) apparent diffusion coefficient ( ADC ) calculate MRI sequence parameter compare histopathology measure mean vascular density grade fibrosis , respectively . The influence contrast agent ( extracellular macromolecular ) agreement image parameter histopathology assess agreement Ktrans derive one compartment two-compartment model assess . The purpose establish standard protocol future clinical trial treatment would use MRI parameter quantitative marker treatment effect .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>1 . &gt; 18 year age . 2 . Biopsy prove pancreatic ductal adenocarcinoma ( PDA ) and/or pancreatic mass imaging feature suggestive pancreatic adenocarcinoma plan surgical resection . 3 . No contraindication MRI severe claustrophobia ( alleviated oral antianxiolytics ) metal/mechanical device body consider magnetic resonance ( MR ) compatible 1.5 Tesla ( departmental MRI safety screen form ) 4 . No known allergy gadolinium base contrast agent 5 . Patient estimate glomerular filtration rate ( GFR ) &gt; 30 mg/dL use modification diet Renal Disease ( MDRD ) formula . 1 . Contraindication MR image 2 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Pancreatic Adenocarcinoma</keyword>
	<keyword>Pancreatic Cancer</keyword>
</DOC>